Erdogan-Trinkaus Ipek — SEC insider filings

SEC reporting owner CIK 2047026. 4 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-12-12 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Eton Pharmaceuticals, Inc. (ETON)Chief Commercial Officer4—2 legs · 3,500 sh · $235,9376

Insider filings — Erdogan-Trinkaus Ipek

FiledFormIssuerReported transactionsSource
2026-11-124Eton Pharmaceuticals, Inc. (ETON)Option exercise (M): 3,500 @ $15.47 · Sale (S): 2,340 @ $67.18 · Sale (S): 1,160 @ $67.88 · Option exercise (M): 3,500 (derivative) @ $0EDGAR
2026-08-044Eton Pharmaceuticals, Inc. (ETON)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2026-01-144Eton Pharmaceuticals, Inc. (ETON)Grant/award (A): 40,655 (derivative) @ $0 · Grant/award (A): 25,856 (derivative) @ $0EDGAR
2025-12-124Eton Pharmaceuticals, Inc. (ETON)Tax withholding (F): 85 @ $16.90EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2047026 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs